- Remote Ischemic Preconditioning Can Prevent Contrast-Induced AKI (CIAKI) by Reducing Neutrophil Extracellular Traps (NETs)
10:00 AM - 12:00 PM
Remote Ischemic Preconditioning Can Prevent Contrast-Induced AKI (CIAKI) by Reducing Neutrophil Extracellular Traps (NETs)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Advancing Community Care and Access to Follow-Up after AKI Hospitalization: The AFTER AKI Randomized Controlled Trial
10:00 AM - 12:00 PM
Advancing Community Care and Access to Follow-Up after AKI Hospitalization: The AFTER AKI Randomized Controlled Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Acute Kidney Disease Detection in an Outpatient Setting: A Pragmatic Randomized Controlled Trial
10:00 AM - 12:00 PM
Acute Kidney Disease Detection in an Outpatient Setting: A Pragmatic Randomized Controlled Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Validation of a Combined Biomarker Including FGF-23, Erythropoietin, and Klotho for Development AKI and Clinical Outcomes in Patients in the Intensive Care Unit (ICU)
10:00 AM - 12:00 PM
Validation of a Combined Biomarker Including FGF-23, Erythropoietin, and Klotho for Development AKI and Clinical Outcomes in Patients in the Intensive Care Unit (ICU)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Evaluation of the Anticoagulant Effect of Effluent Ionized Calcium iCa to Measure Regional Citrate Anticoagulation (RCA) Performance vs. Post-filter Ionized Calcium iCa: A Single-Center Non-inferiority Randomized Controlled Trial (RCT)
10:00 AM - 12:00 PM
Evaluation of the Anticoagulant Effect of Effluent Ionized Calcium iCa to Measure Regional Citrate Anticoagulation (RCA) Performance vs. Post-filter Ionized Calcium iCa: A Single-Center Non-inferiority Randomized Controlled Trial (RCT)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Sodium Zirconium Cyclosilicate (SZC) to Enable Renin Angiotensin-Aldosterone System Inhibitor (RAASi) Use for Diabetic Kidney Disease: The CRYSTAL Study
10:00 AM - 12:00 PM
Sodium Zirconium Cyclosilicate (SZC) to Enable Renin Angiotensin-Aldosterone System Inhibitor (RAASi) Use for Diabetic Kidney Disease: The CRYSTAL Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Can Exogenous Ketones Prevent the Effects of High Salt on Renal Vascular Resistance during Sympathoexcitation?
10:00 AM - 12:00 PM
Can Exogenous Ketones Prevent the Effects of High Salt on Renal Vascular Resistance during Sympathoexcitation?
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Immunosuppression Minimization In Kidney Transplant Recipients with Transplant Excellence Based on the TruGraf Test
10:00 AM - 12:00 PM
Immunosuppression Minimization In Kidney Transplant Recipients with Transplant Excellence Based on the TruGraf Test
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Social Network Interventions to Reduce Racial/Ethnic Living Donor Kidney Transplants (LDKT) Disparities: Preliminary Results from the Friends and Family of Kidney Transplant Patients Study
10:00 AM - 12:00 PM
Social Network Interventions to Reduce Racial/Ethnic Living Donor Kidney Transplants (LDKT) Disparities: Preliminary Results from the Friends and Family of Kidney Transplant Patients Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- VIRENO Study: A Novel Approach for Early Outcome Prediction after Kidney Transplantation
10:00 AM - 12:00 PM
VIRENO Study: A Novel Approach for Early Outcome Prediction after Kidney Transplantation
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Phase I/IIa Trial of Autologous Regulatory T Cell Therapy Together with Donor Bone Marrow Infusion in Kidney Transplantation
10:00 AM - 12:00 PM
Phase I/IIa Trial of Autologous Regulatory T Cell Therapy Together with Donor Bone Marrow Infusion in Kidney Transplantation
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Hypertension Management App for Salt Restriction in Patients with CKD: The CureApp-CKD Trial
10:00 AM - 12:00 PM
A Hypertension Management App for Salt Restriction in Patients with CKD: The CureApp-CKD Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Rilparencel Autologous Cell Therapy in Patients with Diabetes and Advanced CKD: Phase 2 Interim Results
10:00 AM - 12:00 PM
Rilparencel Autologous Cell Therapy in Patients with Diabetes and Advanced CKD: Phase 2 Interim Results
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Radiofrequency Renal Denervation in Patients with Severe CKD, Including Patients on Dialysis: Analysis from the Global SYMPLICITY Registry DEFINE
10:00 AM - 12:00 PM
Radiofrequency Renal Denervation in Patients with Severe CKD, Including Patients on Dialysis: Analysis from the Global SYMPLICITY Registry DEFINE
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Impact of Adjunctive Active Vitamin D on Kidney Function during Treatment of Secondary Hyperparathyroidism (SHPT) with Extended-Release Calcifediol (ERC) in Nondialysis-Dependent CKD (ND-CKD)
10:00 AM - 12:00 PM
Impact of Adjunctive Active Vitamin D on Kidney Function during Treatment of Secondary Hyperparathyroidism (SHPT) with Extended-Release Calcifediol (ERC) in Nondialysis-Dependent CKD (ND-CKD)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Evaluation of an At-Home Creatinine Assay for CKD Management: Pilot Method Comparison Study and Clinical Implications
10:00 AM - 12:00 PM
Evaluation of an At-Home Creatinine Assay for CKD Management: Pilot Method Comparison Study and Clinical Implications
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Efficacy and Safety of AND017 for Treatment of Anemia in Dialysis-Dependent CKD
10:00 AM - 12:00 PM
Efficacy and Safety of AND017 for Treatment of Anemia in Dialysis-Dependent CKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Hemodialysis with Citrate on Vascular Calcification
10:00 AM - 12:00 PM
Effect of Hemodialysis with Citrate on Vascular Calcification
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Double vs. Single Icodextrin Dose in Older Incident Patients on Incremental Continuous Ambulatory Peritoneal Dialysis (CAPD): Results from the DIDo (Double Icodextrin Dose) Study
10:00 AM - 12:00 PM
Double vs. Single Icodextrin Dose in Older Incident Patients on Incremental Continuous Ambulatory Peritoneal Dialysis (CAPD): Results from the DIDo (Double Icodextrin Dose) Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Community Health Worker Intervention for Latinos Receiving Hemodialysis: A Randomized Controlled Trial
10:00 AM - 12:00 PM
Community Health Worker Intervention for Latinos Receiving Hemodialysis: A Randomized Controlled Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Cost Utility of High-Dose Online Hemodiafiltration Compared with High-Flux Hemodialysis: Economic Evaluation of the Multinational, Randomized Controlled CONVINCE Trial
10:00 AM - 12:00 PM
Cost Utility of High-Dose Online Hemodiafiltration Compared with High-Flux Hemodialysis: Economic Evaluation of the Multinational, Randomized Controlled CONVINCE Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Ferric Citrate for the Prevention of Renal Failure in Adults with Advanced CKD: The FRONTIER Trial
10:00 AM - 12:00 PM
Ferric Citrate for the Prevention of Renal Failure in Adults with Advanced CKD: The FRONTIER Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effects of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia
10:00 AM - 12:00 PM
Effects of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Which Patients Benefit the Most from Hemodiafiltration Compared with Hemodialysis? Prediction of Individualized Treatment Effects
10:00 AM - 12:00 PM
Which Patients Benefit the Most from Hemodiafiltration Compared with Hemodialysis? Prediction of Individualized Treatment Effects
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Amino Acids Supplementation and Exercise Intervention in Hemodialysis Patients: Effects on Muscle and Fatigue, A Randomized Controlled Trial
10:00 AM - 12:00 PM
Amino Acids Supplementation and Exercise Intervention in Hemodialysis Patients: Effects on Muscle and Fatigue, A Randomized Controlled Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Long-Term Experience of Treating CKD-Associated Pruritus (CKD-aP) with Difelikefalin at a Large Dialysis Organization in the United States
10:00 AM - 12:00 PM
Long-Term Experience of Treating CKD-Associated Pruritus (CKD-aP) with Difelikefalin at a Large Dialysis Organization in the United States
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Crossover Trial
10:00 AM - 12:00 PM
DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Crossover Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Real-World Effectiveness of Patiromer among Hemodialysis (HD) Patients: 1-Year Follow-Up on a Retrospective Cohort
10:00 AM - 12:00 PM
Real-World Effectiveness of Patiromer among Hemodialysis (HD) Patients: 1-Year Follow-Up on a Retrospective Cohort
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- SPARKLE: A Multicenter, Open-Label Study to Evaluate the Safety and Diagnostic Efficacy of ACE-MBCA in Patients with Known or Suspected Focal Liver Lesions and Severe Renal Impairment
10:00 AM - 12:00 PM
SPARKLE: A Multicenter, Open-Label Study to Evaluate the Safety and Diagnostic Efficacy of ACE-MBCA in Patients with Known or Suspected Focal Liver Lesions and Severe Renal Impairment
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Azithromycin for the Prevention of Hemolytic Uremic Syndrome in Shiga Toxin-Positive Diarrhea: A Proof of Concept
10:00 AM - 12:00 PM
Azithromycin for the Prevention of Hemolytic Uremic Syndrome in Shiga Toxin-Positive Diarrhea: A Proof of Concept
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- GFR Changes Following Urinary Tract Infection (UTI) in Children with Vesicoureteral Reflux (VUR)
10:00 AM - 12:00 PM
GFR Changes Following Urinary Tract Infection (UTI) in Children with Vesicoureteral Reflux (VUR)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Pravastatin on Kidney Disease Outcomes in Adult Patients with Early-Stage Autosomal Dominant Polycystic Kidney Disease
10:00 AM - 12:00 PM
Effect of Pravastatin on Kidney Disease Outcomes in Adult Patients with Early-Stage Autosomal Dominant Polycystic Kidney Disease
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Outcomes of the DUPLEX Trial in Patients with Genetic Focal Segmental Glomerulosclerosis (gFSGS)
10:00 AM - 12:00 PM
Outcomes of the DUPLEX Trial in Patients with Genetic Focal Segmental Glomerulosclerosis (gFSGS)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- RGLS8429 Increases Urinary PC1 and PC2 and May Reduce Height-Adjusted Total Kidney Volume (htTKV) in Patients with ADPKD
10:00 AM - 12:00 PM
RGLS8429 Increases Urinary PC1 and PC2 and May Reduce Height-Adjusted Total Kidney Volume (htTKV) in Patients with ADPKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Stopping Eculizumab Treatment Safely in Atypical Haemolytic Uraemic Syndrome (SETS aHUS): A Multicentre, Open-Label, Prospective, Single-Arm Trial of the Safety and Impact of Eculizumab Withdrawal
10:00 AM - 12:00 PM
Stopping Eculizumab Treatment Safely in Atypical Haemolytic Uraemic Syndrome (SETS aHUS): A Multicentre, Open-Label, Prospective, Single-Arm Trial of the Safety and Impact of Eculizumab Withdrawal
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Rituximab for Adult-Onset Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
10:00 AM - 12:00 PM
Rituximab for Adult-Onset Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- AMPLITUDE: A Phase 2/3 Adaptive Trial of Inaxaplin in APOL1-Mediated Kidney Disease
10:00 AM - 12:00 PM
AMPLITUDE: A Phase 2/3 Adaptive Trial of Inaxaplin in APOL1-Mediated Kidney Disease
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Zanubrutinib for the Treatment of Primary Membranous Nephropathy (PMN): Results of a Single-Arm Feasibility Study
10:00 AM - 12:00 PM
Zanubrutinib for the Treatment of Primary Membranous Nephropathy (PMN): Results of a Single-Arm Feasibility Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Phase II Results of an Investigational RNA Therapeutic to Complement Factor B, IONIS-FB-LRx, for Treatment of IgA Nephropathy
10:00 AM - 12:00 PM
Phase II Results of an Investigational RNA Therapeutic to Complement Factor B, IONIS-FB-LRx, for Treatment of IgA Nephropathy
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Single-Center, Phase 2, Open-Label Trial Evaluating the Efficacy and Safety of Obinutuzumab in Treatment of Immunosuppression-Resistant Primary FSGS, or Contraindication to High-Dose Corticosteroids
10:00 AM - 12:00 PM
Single-Center, Phase 2, Open-Label Trial Evaluating the Efficacy and Safety of Obinutuzumab in Treatment of Immunosuppression-Resistant Primary FSGS, or Contraindication to High-Dose Corticosteroids
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
